Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:03 PM
Ignite Modification Date:
2025-12-24 @ 2:03 PM
NCT ID:
NCT01578395
Eligibility Criteria:
Inclusion criteria:
* Male or Female
* 18-70 years of age
* European origin
* Non-smoker
* 30 patients with high-dose radiation exposure from a cardiac examination
* 30 patients with low-dose radiation exposure from a cardiac examination
* 30 subjects without radiation exposure
* Given written informed consent
* Ability to participate in the study
Exclusion criteria:
* no known intolerance against one of the applied study drugs or against substances used for formulation of one of the study drugs or against other drugs with similar chemical structures as one of the study drugs
* Leukemia
* Lymphoma
* Radio- or chemotherapy
* Severe renal failure (GFR\<30 ml/min)
* Positive pregnancy test or lactation
* Radiation-based examination within the last 3 days
* Known glucose-6-phosphate-dehydrogenase deficiency
* Known nephrolithiasis (calciumoxalate calculus)
* Intake of barbiturates, tetracyclines, corticosteroids within the last 4 weeks
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01578395
Study Brief:
Protocol Section:
NCT01578395